RAPP
Rapport Therapeutics, Inc.
27.02
+1.06 (+4.08%)
52w low 22.06
52.93 high
16.1% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | -- | -17.46M | -24.70M | -13.06M | -41.45M | -41.63M | |
| Depreciation & Amort | -- | -- | 256.00K | 265.00K | 227.00K | 212.00K | 198.00K | |
| Capital Expenditure | -- | -22.00K | -134.00K | -169.00K | -86.00K | -78.00K | -- | |
| Free Cash Flow | -- | -- | -17.60M | -24.87M | -13.15M | -41.53M | -41.63M | |
| Investing Cash Flow | -- | -- | -56.78M | -174.32M | 37.94M | 25.60M | 51.06M | |
| Financing Cash Flow | -- | -- | 270.53M | 311.00K | 531.00K | 1.41M | 1.71M | |
| Share Buybacks | -- | -- | 0.00 | 0.00 | -5.00K | 0.00 | 0.00 |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--